Searched for
BIOCON PROFIT SURGE
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Stocks in news: TCS, HDFC Bank, ITC Hotels, Hyundai India, Adani EnterprisesMarkets surged for the fourth consecutive session, buoyed by favorable geopolitical cues. Key stocks like TCS, HDFC Bank, ITC Hotels, Hyund...
- Biocon shares rise 2% after USFDA approval for osteoporosis and bone loss drugsShares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab b...
- Syngene International reports 11% revenue growth and 59% net profit surge in Q1Syngene International, a Biocon subsidiary, reveals an 11% revenue increase to Rs 875 crore for the first quarter. Net profit jumps 59% to ...
- Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran ShawBiocon is planning a ₹4,500 crore fundraise to increase promoter stake in Biocon Biologics and convert structured venture debt into equity,...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Biocon shares in focus as Q4 PAT soars 153% YoYBiocon shares: The company also reported consolidated revenue of Rs 4,454 crore, reflecting a 15% year-on-year increase on a like-for-like ...
- Biocon Q4 results: Net profit surges 153% at Rs 344 croreBiocon reported a significant surge in Q4 net profit, up 153% to Rs 344 crore, with revenue growing 12% to Rs 4,454 crore. The company's bi...
- Biocon shares jump 8% post Q4 results. Is the Street happy?Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings growth. Net profit grew by 31% to INR 313 crore with 57% YoY growth in co...
- Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57%The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while...
- Kotak fund invests Rs 1070 crore in BioconEshwar Karra, CEO – Kotak Special Situations Fund at Kotak Investment Advisors said, We are delighted to partner with Biocon and this acqui...
- Biocon Q3 Results: Firm posts Rs 42 cr loss on one-time exceptional itemThe profit was also impacted due to dilution of Biocon’s stake in Biocon Biologics and Syngene. Net profit for the quarter, excluding an ex...
- Biocon surges on USFDA's cancer drug approvalFor the quarter ended March 31, 2017, Biocon reported total revenue at Rs 632.10 crore and net profit stood at 203.80 crore.
- Biocon shares hit 2-week high post Q3 numbersConsolidated total income from operations also increased to Rs 1,044.4 crore for the quarter under review as against Rs 807.1 crore in the ...
- Stocks: The hits and missesReliance shares surged 4.7% to Rs 747.25 on short-covering after Kotak Securities maintained its buy rating on the stock.
- Biocon Q4 profit up three-fold; FY'10 net at Rs 293 crPharma major Biocon Ltd on Thursday posted a jump of over three-fold in its consolidated net profit to Rs 80.62 crore for the fourth quarte...
- Biocon Oct-Dec net profit up 500% YoYBiocon Ltd reported a net profit of Rs 284.04 crore for the quarter ended December 31, 2007, a surge of 497.85 per cent from Rs 47.51 crore...
Load More
